Composition of the highest governance body and its committees Proxy Statement for Teva's 2020 Annual Shareholder Meeting, page 15 for information on director independence, executive/non-executive, age, tenure and gender; pages 8-13 for other significant positions and commitments and qualifications for service; page 16 for competencies 102-23 Chair of the highest governance body Proxy Statement for Teva’s 2020 Annual Shareholder Meeting, page 17; Teva's non-executive chairman of the board is Dr. Sol Barer.